Ilyas Sahin MD

Summary

• Dr. Ilyas Sahin is an oncology specialist based in Boston, MA, with a subspecialization in gastrointestinal cancers. He completed his fellowship in Hematology and Medical Oncology at Brown University from 2017 to 2020. Dr. Sahin is currently an oncologist at Massachusetts General Hospital (MGH) and a faculty member at Harvard Medical School, where he focuses on early-phase clinical trials and targeted therapies.
  
  With a career dedicated to advancing cancer treatments, Dr. Sahin’s work centers on overcoming immunotherapy resistance and enhancing personalized medicine to meet the unique needs of each patient. At MGH, he plays a key role in Phase 1 clinical trials, translating groundbreaking scientific discoveries into novel therapies for cancer patients.
  
  Dr. Sahin has a strong clinical and research interest in esophageal and gastric cancers, hepatocellular carcinoma (HCC), and liver metastases from other tumors. He is actively involved in developing innovative treatment strategies for liver metastasis, aiming to improve outcomes for patients with complex liver involvement across various cancer types.
  
  In addition to his research efforts, Dr. Sahin is known for his compassionate and comprehensive approach to patient care. He integrates the latest scientific advances into individualized treatment plans, ensuring each patient receives the most effective, evidence-based care possible.